About Vysali Pharmaceuticals Ltd
Data last updated:
Vysali Pharmaceuticals Ltd is a public limited company based in Ernakulam, Kerala, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 October 1979.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24231KL1979PLC003112. Its GSTIN is 32AAACV5491P1ZU (Kerala).
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹5.43 Cr. It is led by directors including Alathur Damodaran Krishnan (Managing Director) and Savithri Krishnan (Whole-Time Director).
Its last annual general meeting (AGM) was held on 26 November 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at IX/639 Vysali Road Edathala P O, Ernakulam, Kerala, India – 683561.
As per the financials filed for FY 2022, the company reported a revenue of ₹2.16 Cr, a decline of 39% compared to the previous year. For the same year it recorded a net loss of ₹4.59 Cr (net margin -212.3%) and EBITDA of -₹63.87 Lakh (EBITDA margin -29.5%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years and 20% over five years.
As per MCA filings, the company has open charges of ₹30.26 Cr and satisfied charges of ₹19.46 Cr on record. Court records list 24 cases involving the company, including 4 filed by the company and 20 filed against it; 3 cases are pending.
The last known website on record is vysalipharma.com.
Company details
Contact details
Vysali Pharmaceuticals Ltd's registered office is in Ernakulam, Kerala. Its website is vysalipharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressIX/639 Vysali Road Edathala P O, Ernakulam, Kerala, India – 683561
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vysali Pharmaceuticals Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Vysali Pharmaceuticals Ltd
FY 2022 filings availableVysali Pharmaceuticals Ltd reported revenue of ₹2.16 Cr (down 39% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 39% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹2.16 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹63.87 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.59 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -29.5% | ||||
| Net Profit Margin | -212.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vysali Pharmaceuticals Ltd, buy the company report.
Board of directors of Vysali Pharmaceuticals Ltd
Vysali Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kizhakkekara Kuriakose Jose | Irp/Rp/Liquidator | 26 Feb 2024 | 2 Years 7 Months | As last reported |
| Valath Subramanian Sheelavelappan | Additional Director | 27 Sep 2019 | 7 Years 0 Months | As last reported |
| Savithri Krishnan | Whole-Time Director | 29 Oct 1979 | 46 Years 11 Months | As last reported |
| Alathur Damodaran Krishnan | Managing Director | 29 Oct 1979 | 46 Years 11 Months | As last reported |
Auditor
Vysali Pharmaceuticals Ltd is audited by Chithrabhanu Kaplingat for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Chithrabhanu Kaplingat | FY 2022 | 015682 |
Shareholding
The shareholding of Vysali Pharmaceuticals Ltd is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vysali Pharmaceuticals Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Sep 2019 | 100287909 | Others | ₹3 Cr | Open | |
| 25 Oct 2007 | 10072135 | Kerala State Industrial Development Corporation Limited | ₹5.59 Cr | Open | |
| 24 Oct 2007 | 10072132 | Kerala State Industrial Development Corporation Limited | ₹5.59 Cr | Open | |
| 14 Jun 2007 | 10054532 | Kerala State Industrial Development Corpn Ltd | ₹5.59 Cr | Open | |
| 13 Jun 2007 | 10054642 | Kerala State Industrial Development Corpn Ltd | ₹5.59 Cr | Open |
To see the full charge records of Vysali Pharmaceuticals Ltd, buy the company report.
Total charge records: 23 View all charges
Legal cases
Vysali Pharmaceuticals Ltd has 24 court cases on record: 4 filed by Vysali Pharmaceuticals, 20 filed against it. 3 cases are pending and 21 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 11 | 7 | 2 |
| District courts | 10 | 10 | 1 |
| NCLT | 3 | 3 | 0 |
Cases on record (5 of 24)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Kochi | Insolvency matter | Filed against the company by Kerala State Industrial Developmentcorpn Ltd | Disposed |
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by Mr. Arunkumar Jamnadas Kochar Director of M/S. Polycaps Baroda Pvt Ltd., | Disposed |
| District court, Ernakulam, Kerala | Criminal case | Filed against the company by Kerala State Industrial Development Corporation Ltd | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by an individual | Pending |
| High Court | Court case (Co.Appl.) | Filed against the company by an individual | Pending |
To see the full case history of Vysali Pharmaceuticals Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vysali Pharmaceuticals Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vysali Pharmaceuticals Ltd has 1 active EPFO establishment as of Apr 07, 2024.
GST
Vysali Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAACV5491P1ZU | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vysali Pharmaceuticals Ltd, buy the company report.
Recent activity
Vysali Pharmaceuticals Ltd has 6 board changes on record since 1979: 4 appointments and 2 cessations. The latest: Francis Mathew ceased to be Irp/Rp/Liquidator on 26 Feb 2024.
40 earlier events are in the company report.
Frequently asked questions
Vysali Pharmaceuticals is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Vysali Pharmaceuticals is a company under liquidation, formerly operating as a public limited company based in Ernakulam, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 October 1979 and is registered under CIN U24231KL1979PLC003112. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Vysali Pharmaceuticals has 4 current directors:
- Alathur Damodaran Krishnan - Managing Director
- Savithri Krishnan - Whole-Time Director
- Valath Subramanian Sheelavelappan - Additional Director
- Kizhakkekara Kuriakose Jose - Irp/Rp/Liquidator
The latest financial statements of Vysali Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 26 November 2022. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Vysali Pharmaceuticals is U24231KL1979PLC003112. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vysali Pharmaceuticals has open charges of ₹30.26 Cr and satisfied charges of ₹19.46 Cr as per latest MCA filings.
Vysali Pharmaceuticals has 24 court cases on record: 4 filed by the company and 20 filed against it. 3 are pending. Most are in the high courts.
Vysali Pharmaceuticals was incorporated on 29 October 1979. It is registered with the Registrar of Companies, Ernakulam.
Francis Mathew ceased to be Irp/Rp/Liquidator on 26 Feb 2024. Kizhakkekara Kuriakose Jose was appointed as Irp/Rp/Liquidator on 26 Feb 2024. Jadhavedhan Namboodiri Ashtathu Manakkal ceased to be Whole-Time Director on 27 Sep 2019. Vysali Pharmaceuticals has 6 board changes on record in total.
Vysali Pharmaceuticals can be reached through the website vysalipharma.com. Its registered office is in Ernakulam, Kerala, India.